Research programme: liver disorders therapy - NicOxAlternative Names: Liver disorders therapy research programme - NicOx; NCX 999
Latest Information Update: 16 May 2007
At a glance
- Originator NicOx
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Liver disorders
Most Recent Events
- 09 Jun 2004 Preclinical trials in Liver disorders in France (unspecified route)